|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61K 31/428 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 31/496 | (2013.01) | ||
| A61P 25/00 | (2018.01) |
| (11) | Number of the document | 3240538 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17712175.3 |
| Date of filing the European patent application | 2017-03-24 | |
| (97) | Date of publication of the European application | 2017-11-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/057134 |
| Date | 2017-03-24 |
| (87) | Number | WO 2017/162884 |
| Date | 2017-09-28 |
| (30) | Number | Date | Country code |
| 16162490 | 2016-03-25 | EP |
| (72) |
MOUSSY, Alain , FR
KINET, Jean-Pierre , FR
MANSFIELD, Colin , FR
|
| (73) |
AB Science ,
3, avenue George V, 75008 Paris,
FR
|
| (54) | USE OF MASITINIB FOR TREATMENT OF AN AMYOTROPHIC LATERAL SCLEROSIS PATIENT SUBPOPULATION |
| USE OF MASITINIB FOR TREATMENT OF AN AMYOTROPHIC LATERAL SCLEROSIS PATIENT SUBPOPULATION |